ArticleAmerican journal of translational research2026
Nomogram for predicting adverse perinatal outcomes in hypertensive disorders of pregnancy complicated by fetal growth restriction.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesHypertensive disorders of pregnancy (HDP) when combined with fetal growth restriction (FGR) increase the risk of adverse perinatal outcomes (APO). This study aimed to investigate the predictive value of fetal hemodynamic indicators for APO and to construct a nomogram for individualized risk assessment in pregnancies with HDP and FGR.
methodsThis retrospective study included 198 pregnant women with HDP and FGR in the training set and 85 patients in the validation set, admitted between January 2022 and December 2024. Demographic, clinical, biochemical (uric acid, free thyroxine [FT4]), and Doppler parameters (umbilical artery pulsatility index [UA-PI], middle cerebral artery PI [MCA-PI], and cerebroplacental ratio [CPR]) were collected. Multivariate logistic regression was used to identify independent predictors, and a nomogram was constructed.
resultsSeven independent predictors were identified: family history of hypertension (odds ratio [OR]=2.986), pre-eclampsia or chronic hypertension with superimposed pre-eclampsia (OR=2.811), uric acid (OR=1.036), FT4 (OR=0.813), abnormal UA-PI (OR=7.262), abnormal MCA-PI (OR=6.620), and abnormal CPR (OR=6.702). The nomogram demonstrated good discrimination, with an area under the curve (AUC] of 0.905 in the training set and 0.806 in the validation set.
conclusionsWe developed a nomogram integrating maternal clinical history, serum biomarkers (uric acid, FT4), and fetal Doppler indices that showed good predictive accuracy for APO in HDP complicated by FGR. External validation in multi-center cohorts is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.